The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Linda Mellbin is Associate Professor of Cardiology and Head of the Coronary Artery Disease Patient Area at Karolinska University Hospital in Stockholm, Sweden.
She obtained her medical degree at Karolinska Institutet in 2000 and, following service at the Department of Medicine at Oskarshamn’s Hospital, she joined the Department of Cardiology at Karolinska University Hospital in 2005. She earned her PhD thesis in 2010 and has thereafter continued research in the field of diabetes and cardiovascular diseases at Karolinska Institutet.
Associate Professor Mellbin has authored several original papers, review articles and book chapters she was project leader for the EAPC (European Association of Preventive Cardiology) Educational Programme on Diabetes and Cardiovascular Disease and she was a member of the European Society of Cardiology Task Force updating the 2013 and 2019 guidelines on diabetes, pre-diabetes and cardiovascular diseases.